Detection of soluble TRAIL in HBV infected patients and its clinical implications

Table 4 Analysis of the correlation between Expression of HBeAg and that of sTRAIL

Group divided by S/N	cases	The expression of HBeAg(S/N)	Expression of sTRAIL in peripheral blood ( × 10-9μg/mL)
< 2.1(-)	14	0.86 ± 0.51	1166.81 ± 448.84
> 2.1 and < 10(+)	9	5.47 ± 2.88	1088.33 ± 528.27a
> 10 and < 30(++)	19	20.79 ± 5.39	1590.26 ± 474.81ab
> 30 and < 50(+++)	4	36.06 ± 4.82	1655.00 ± 534.48a
> 50(++++)	6	54.69 ± 4.49	1730.83 ± 652.64bc

^aP < 0.05 vs the negative group;

^bP < 0.01 vs the negative group;

^cP < 0.05 vs the mildly positive group(+)